Paul W Sandman - Net Worth and Insider Trading
Paul W Sandman Net Worth
The estimated net worth of Paul W Sandman is at least $12 Million dollars as of 2024-05-05. Paul W Sandman is the SVP and General Counsel of Boston Scientific Corp and owns about 166,188 shares of Boston Scientific Corp (BSX) stock worth over $12 Million. Details can be seen in Paul W Sandman's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Paul W Sandman has not made any transactions after 2003-12-15 and currently still holds the listed stock(s).
Transaction Summary of Paul W Sandman
Paul W Sandman Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Paul W Sandman owns 2 companies in total, including PDL BioPharma Inc (PDLI) , and Boston Scientific Corp (BSX) .
Click here to see the complete history of Paul W Sandman’s form 4 insider trades.
Insider Ownership Summary of Paul W Sandman
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| PDLI | PDL BioPharma Inc | 2019-06-20 | director |
| BSX | Boston Scientific Corp | 2003-12-15 | Sr. VP and General Counsel |
Paul W Sandman Latest Holdings Summary
Paul W Sandman currently owns a total of 1 stock. Paul W Sandman owns 166,188 shares of Boston Scientific Corp (BSX) as of December 15, 2003, with a value of $12 Million.
Latest Holdings of Paul W Sandman
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| BSX | Boston Scientific Corp | 2003-12-15 | 166,188 | 72.85 | 12,106,796 |
Holding Weightings of Paul W Sandman
Paul W Sandman Form 4 Trading Tracker
According to the SEC Form 4 filings, Paul W Sandman has made a total of 0 transactions in Boston Scientific Corp (BSX) over the past 5 years. The most-recent trade in Boston Scientific Corp is the sale of 50,000 shares on December 15, 2003, which brought Paul W Sandman around $2 Million.
Insider Trading History of Paul W Sandman
- 1
Paul W Sandman Trading Performance
Paul W Sandman Ownership Network
Paul W Sandman Owned Company Details
What does PDL BioPharma Inc do?
Who are the key executives at PDL BioPharma Inc?
Paul W Sandman is the director of PDL BioPharma Inc. Other key executives at PDL BioPharma Inc include President and CEO Dominique Monnet , VP & Gen. Counsel & Secretary Christopher Lewis Stone , and VP Finance & CAO and Acting CFO Edward Imbrogno .
PDL BioPharma Inc (PDLI) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of PDL BioPharma Inc (PDLI) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of PDL BioPharma Inc (PDLI) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
PDL BioPharma Inc (PDLI)'s detailed insider trading history can be found in Insider Trading Tracker table.
PDL BioPharma Inc Insider Transactions
Paul W Sandman Mailing Address
Above is the net worth, insider trading, and ownership report for Paul W Sandman. You might contact Paul W Sandman via mailing address: C/o Pdl Biopharma, Inc., 932 Southwood Blvd, Incline Village Nv 89451.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
